ABBV Income Statement

AbbVie Inc - Revenue, Expenses & Profit Analysis

Stock Price

$248.08

Market Cap

$334.34B

P/E Ratio

80.5

Most Recent Quarter

Period: FY(2025-12-31)

Revenue

Total sales from operations

$61.16B

+305.0% YoY

Cost of Revenue

Direct costs of sales

$18.20B

Gross Profit

Revenue - Cost of Revenue

$42.96B

Operating Income

Gross Profit - Operating Expenses

$15.07B

Interest Expense

Cost of debt

$2.89B

Net Income

Bottom line profit

$4.23B

Earnings Per Share (Diluted)

Net income per share

$2.36

Profitability Metrics

Historical Income Statements

PeriodRevenueGross ProfitOperating IncomeNet IncomeEPS
FY$61.16B$42.96B$15.07B$4.23B$2.36
2024-12-31$15.10B--$4.29B$-0.02
FY$56.33B$39.43B$9.14B$4.28B$2.39
FY$54.32B$33.90B$12.76B$4.86B$2.72
2023-12-31$14.30B--$4.87B$0.46

View Complete Financial Analysis

Full income statements, balance sheets, cash flows, and AI-powered insights

Open Full Analysis

Frequently Asked Questions

What is ABBV's revenue?

ABBV's most recent quarterly revenue was $61.16B, representing a growth of 305.0% year-over-year.

Is ABBV profitable?

ABBV reported a profit of $4.23B in the most recent quarter.

What is ABBV's operating income?

ABBV's operating income was $15.07B in the most recent quarter.

What is ABBV's earnings per share (EPS)?

ABBV reported diluted earnings per share of $2.36 in the most recent quarter.

What is ABBV's gross profit margin?

Gross margin data is available in the profitability metrics section.

Explore Categories